The FreeMind Group is proud to support the upcoming Trans-Pacific Health Science Dialogue!
Where: Boston, MA
When: September 28-29, 2016
Big Players Are Making Big Bets on Biopharma in Asia
- Chinese investors representing more than $5.5B are looking for Trans-Pacific investments
- Pfizer is investing $150M in a biologics plant in China
- BMS expects Opdivo sales in Japan to exceed $1B
- The Hangzhou Economic Development Area is investing $350M in a global biotech center
Can You Afford to Sit on the Sidelines?
The time to think about establishing, expanding or accelerating an Asian strategy is now. With a lineup of top Asia experts, the Trans-Pacific Health Sciences Dialogue will provide you with a solid grasp of Asian biopharma opportunities and today’s best strategies for market entry and growth. This two-day event provides critical insights you will not find at any other meeting.
For complete details and to register go to: